back to cluster viewer
cluster path 1110101111100
121 words, 143,392 tokens
freq alpha suffix
Words in frequency order
1 | significantly | 143,048
|
2 | nonsignificantly | 188
|
3 | 'minimally | 8
|
4 | starkly | 5
|
5 | signifcantly | 4
|
6 | near-significantly | 3
|
7 | signicantly | 3
|
8 | significanty | 3
|
9 | significiantly | 3
|
10 | 1.53-fold | 2
|
11 | 13.5-fold | 2
|
12 | 2.16-fold | 2
|
13 | 4.5-times | 2
|
14 | hba1cs | 2
|
15 | meats/cheeses | 2
|
16 | near-linearly | 2
|
17 | observably | 2
|
18 | remarkablely | 2
|
19 | signi-ficantly | 2
|
20 | significanlty | 2
|
21 | significantlly | 2
|
22 | singificantly | 2
|
23 | to-follow-up | 2
|
24 | ~4.4-fold | 2
|
25 | *1.5-fold | 1
|
26 | -.88 | 1
|
27 | -22.4/h | 1
|
28 | 0.32°c | 1
|
29 | 0.40-log | 1
|
30 | 0.64-fold | 1
|
31 | 0.6g | 1
|
32 | 0·2°c | 1
|
33 | 1,3-fold | 1
|
34 | 1.1-1.6-fold | 1
|
35 | 1.1-day | 1
|
36 | 1.2-1.8-fold | 1
|
37 | 1.5-73-fold | 1
|
38 | 1.6× | 1
|
39 | 1.8-2.3-fold | 1
|
40 | 1.824-fold | 1
|
41 | 1.9-times | 1
|
42 | 1000-10,000-fold | 1
|
43 | 1000-times | 1
|
44 | 15943a | 1
|
45 | 18.4-times | 1
|
46 | 18.5-fold | 1
|
47 | 1·37-fold | 1
|
48 | 2,078-fold | 1
|
49 | 2.03-fold | 1
|
50 | 2.1-/4.6-fold | 1
|
51 | 2.3-times | 1
|
52 | 2.4-5.8-fold | 1
|
53 | 2.9-folds | 1
|
54 | 21-times | 1
|
55 | 29-times | 1
|
56 | 29.2mg/dl | 1
|
57 | 3.1-times | 1
|
58 | 3.29-fold | 1
|
59 | 3.5-times | 1
|
60 | 3.58-fold | 1
|
61 | 36-times | 1
|
62 | 39.3-fold | 1
|
63 | 3·8-fold | 1
|
64 | 4-6× | 1
|
65 | 4-7-fold | 1
|
66 | 49.5m | 1
|
67 | 4·4-fold | 1
|
68 | 5.11-fold | 1
|
69 | 536-times | 1
|
70 | 6.15-fold | 1
|
71 | 6.3-times | 1
|
72 | 63.1mg/dl | 1
|
73 | 7.4-426-fold | 1
|
74 | 77-fold | 1
|
75 | 99-fold | 1
|
76 | arm.significantly | 1
|
77 | asignificantly | 1
|
78 | borderlinely | 1
|
79 | disruption'- | 1
|
80 | euro28.15 | 1
|
81 | half-a-day | 1
|
82 | high-statistically | 1
|
83 | marginally/statistically | 1
|
84 | micturated | 1
|
85 | n6-cyclopentyladenosine | 1
|
86 | noncompulsory | 1
|
87 | obviouly | 1
|
88 | overridingly | 1
|
89 | participation’ | 1
|
90 | performed.fasting | 1
|
91 | pure-muscle | 1
|
92 | signifcicantly | 1
|
93 | signiticantly | 1
|
94 | signicantly | 1
|
95 | singicantly | 1
|
96 | somewhate | 1
|
97 | use/painperi-operative | 1
|
98 | volume-in | 1
|
99 | weight-exposure | 1
|
100 | well-appointed | 1
|
101 | yielder | 1
|
102 | ~0.4°c | 1
|
103 | ~10x | 1
|
104 | ~25-fold | 1
|
105 | ~3× | 1
|
106 | ~7.5°c | 1
|
107 | ~90,000-fold | 1
|
108 | ~twofold | 1
|
109 | £138.21 | 1
|
110 | £1744 | 1
|
111 | £267 | 1
|
112 | £80 | 1
|
113 | €125 | 1
|
114 | €838 | 1
|
115 | ∼15-fold | 1
|
116 | ∼24-fold | 1
|
117 | ∼3.7-fold | 1
|
118 | ≈1.5-fold | 1
|
119 | ≈20°c | 1
|
120 | ≥130-fold | 1
|
121 | ≥3.9-fold | 1
|
Words in alphabetical order
1 | 'minimally | 8
|
2 | *1.5-fold | 1
|
3 | -.88 | 1
|
4 | -22.4/h | 1
|
5 | 0.32°c | 1
|
6 | 0.40-log | 1
|
7 | 0.64-fold | 1
|
8 | 0.6g | 1
|
9 | 0·2°c | 1
|
10 | 1,3-fold | 1
|
11 | 1.1-1.6-fold | 1
|
12 | 1.1-day | 1
|
13 | 1.2-1.8-fold | 1
|
14 | 1.5-73-fold | 1
|
15 | 1.53-fold | 2
|
16 | 1.6× | 1
|
17 | 1.8-2.3-fold | 1
|
18 | 1.824-fold | 1
|
19 | 1.9-times | 1
|
20 | 1000-10,000-fold | 1
|
21 | 1000-times | 1
|
22 | 13.5-fold | 2
|
23 | 15943a | 1
|
24 | 18.4-times | 1
|
25 | 18.5-fold | 1
|
26 | 1·37-fold | 1
|
27 | 2,078-fold | 1
|
28 | 2.03-fold | 1
|
29 | 2.1-/4.6-fold | 1
|
30 | 2.16-fold | 2
|
31 | 2.3-times | 1
|
32 | 2.4-5.8-fold | 1
|
33 | 2.9-folds | 1
|
34 | 21-times | 1
|
35 | 29-times | 1
|
36 | 29.2mg/dl | 1
|
37 | 3.1-times | 1
|
38 | 3.29-fold | 1
|
39 | 3.5-times | 1
|
40 | 3.58-fold | 1
|
41 | 36-times | 1
|
42 | 39.3-fold | 1
|
43 | 3·8-fold | 1
|
44 | 4-6× | 1
|
45 | 4-7-fold | 1
|
46 | 4.5-times | 2
|
47 | 49.5m | 1
|
48 | 4·4-fold | 1
|
49 | 5.11-fold | 1
|
50 | 536-times | 1
|
51 | 6.15-fold | 1
|
52 | 6.3-times | 1
|
53 | 63.1mg/dl | 1
|
54 | 7.4-426-fold | 1
|
55 | 77-fold | 1
|
56 | 99-fold | 1
|
57 | arm.significantly | 1
|
58 | asignificantly | 1
|
59 | borderlinely | 1
|
60 | disruption'- | 1
|
61 | euro28.15 | 1
|
62 | half-a-day | 1
|
63 | hba1cs | 2
|
64 | high-statistically | 1
|
65 | marginally/statistically | 1
|
66 | meats/cheeses | 2
|
67 | micturated | 1
|
68 | n6-cyclopentyladenosine | 1
|
69 | near-linearly | 2
|
70 | near-significantly | 3
|
71 | noncompulsory | 1
|
72 | nonsignificantly | 188
|
73 | observably | 2
|
74 | obviouly | 1
|
75 | overridingly | 1
|
76 | participation’ | 1
|
77 | performed.fasting | 1
|
78 | pure-muscle | 1
|
79 | remarkablely | 2
|
80 | signi-ficantly | 2
|
81 | signicantly | 3
|
82 | signifcantly | 4
|
83 | signifcicantly | 1
|
84 | significanlty | 2
|
85 | significantlly | 2
|
86 | significantly | 143,048
|
87 | significanty | 3
|
88 | significiantly | 3
|
89 | signiticantly | 1
|
90 | signicantly | 1
|
91 | singicantly | 1
|
92 | singificantly | 2
|
93 | somewhate | 1
|
94 | starkly | 5
|
95 | to-follow-up | 2
|
96 | use/painperi-operative | 1
|
97 | volume-in | 1
|
98 | weight-exposure | 1
|
99 | well-appointed | 1
|
100 | yielder | 1
|
101 | ~0.4°c | 1
|
102 | ~10x | 1
|
103 | ~25-fold | 1
|
104 | ~3× | 1
|
105 | ~4.4-fold | 2
|
106 | ~7.5°c | 1
|
107 | ~90,000-fold | 1
|
108 | ~twofold | 1
|
109 | £138.21 | 1
|
110 | £1744 | 1
|
111 | £267 | 1
|
112 | £80 | 1
|
113 | €125 | 1
|
114 | €838 | 1
|
115 | ∼15-fold | 1
|
116 | ∼24-fold | 1
|
117 | ∼3.7-fold | 1
|
118 | ≈1.5-fold | 1
|
119 | ≈20°c | 1
|
120 | ≥130-fold | 1
|
121 | ≥3.9-fold | 1
|
Words in suffix order
1 | disruption'- | 1
|
2 | £80 | 1
|
3 | £138.21 | 1
|
4 | £1744 | 1
|
5 | euro28.15 | 1
|
6 | €125 | 1
|
7 | £267 | 1
|
8 | €838 | 1
|
9 | -.88 | 1
|
10 | 15943a | 1
|
11 | ≈20°c | 1
|
12 | 0.32°c | 1
|
13 | 0·2°c | 1
|
14 | ~0.4°c | 1
|
15 | ~7.5°c | 1
|
16 | micturated | 1
|
17 | well-appointed | 1
|
18 | 1000-10,000-fold | 1
|
19 | ~90,000-fold | 1
|
20 | ≥130-fold | 1
|
21 | 5.11-fold | 1
|
22 | 1,3-fold | 1
|
23 | 1.8-2.3-fold | 1
|
24 | 39.3-fold | 1
|
25 | 2.03-fold | 1
|
26 | 1.53-fold | 2
|
27 | 1.5-73-fold | 1
|
28 | ~4.4-fold | 2
|
29 | 1.824-fold | 1
|
30 | ∼24-fold | 1
|
31 | 0.64-fold | 1
|
32 | 4·4-fold | 1
|
33 | *1.5-fold | 1
|
34 | ≈1.5-fold | 1
|
35 | 13.5-fold | 2
|
36 | 18.5-fold | 1
|
37 | 6.15-fold | 1
|
38 | ∼15-fold | 1
|
39 | ~25-fold | 1
|
40 | 1.1-1.6-fold | 1
|
41 | 2.1-/4.6-fold | 1
|
42 | 2.16-fold | 2
|
43 | 7.4-426-fold | 1
|
44 | 4-7-fold | 1
|
45 | ∼3.7-fold | 1
|
46 | 1·37-fold | 1
|
47 | 77-fold | 1
|
48 | 1.2-1.8-fold | 1
|
49 | 2.4-5.8-fold | 1
|
50 | 3.58-fold | 1
|
51 | 2,078-fold | 1
|
52 | 3·8-fold | 1
|
53 | ≥3.9-fold | 1
|
54 | 3.29-fold | 1
|
55 | 99-fold | 1
|
56 | ~twofold | 1
|
57 | pure-muscle | 1
|
58 | n6-cyclopentyladenosine | 1
|
59 | weight-exposure | 1
|
60 | somewhate | 1
|
61 | use/painperi-operative | 1
|
62 | 0.6g | 1
|
63 | performed.fasting | 1
|
64 | 0.40-log | 1
|
65 | -22.4/h | 1
|
66 | 63.1mg/dl | 1
|
67 | 29.2mg/dl | 1
|
68 | 49.5m | 1
|
69 | volume-in | 1
|
70 | to-follow-up | 2
|
71 | yielder | 1
|
72 | hba1cs | 2
|
73 | 2.9-folds | 1
|
74 | 1000-times | 1
|
75 | 3.1-times | 1
|
76 | 21-times | 1
|
77 | 2.3-times | 1
|
78 | 6.3-times | 1
|
79 | 18.4-times | 1
|
80 | 3.5-times | 1
|
81 | 4.5-times | 2
|
82 | 36-times | 1
|
83 | 536-times | 1
|
84 | 1.9-times | 1
|
85 | 29-times | 1
|
86 | meats/cheeses | 2
|
87 | ~10x | 1
|
88 | 1.1-day | 1
|
89 | half-a-day | 1
|
90 | observably | 2
|
91 | remarkablely | 2
|
92 | borderlinely | 1
|
93 | overridingly | 1
|
94 | starkly | 5
|
95 | high-statistically | 1
|
96 | marginally/statistically | 1
|
97 | 'minimally | 8
|
98 | significantlly | 2
|
99 | near-linearly | 2
|
100 | signifcantly | 4
|
101 | signifcicantly | 1
|
102 | signi-ficantly | 2
|
103 | singificantly | 2
|
104 | significantly | 143,048
|
105 | near-significantly | 3
|
106 | arm.significantly | 1
|
107 | asignificantly | 1
|
108 | nonsignificantly | 188
|
109 | singicantly | 1
|
110 | signicantly | 3
|
111 | signiticantly | 1
|
112 | signicantly | 1
|
113 | significiantly | 3
|
114 | obviouly | 1
|
115 | noncompulsory | 1
|
116 | significanlty | 2
|
117 | significanty | 3
|
118 | ~3× | 1
|
119 | 4-6× | 1
|
120 | 1.6× | 1
|
121 | participation’ | 1
|